These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Generation of nitric oxide from organic nitrovasodilators during passage through the coronary vascular bed and its role in coronary vasodilation and nitrate tolerance. Schrör K; Woditsch I; Förster S Blood Vessels; 1991; 28(1-3):62-6. PubMed ID: 1900446 [TBL] [Abstract][Full Text] [Related]
3. On-line measurement of nitric oxide release from organic nitrates in the intact coronary circulation. Schrör K; Förster S; Woditsch I Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):240-6. PubMed ID: 1719435 [TBL] [Abstract][Full Text] [Related]
4. Generation of NO from molsidomine (SIN-1) in vitro and its relationship to changes in coronary vessel tone. Schrör K; Förster S; Woditsch I; Schröder H J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S29-34. PubMed ID: 2484696 [TBL] [Abstract][Full Text] [Related]
5. The nitric oxide donor SIN-1 is free of tolerance and maintains its cyclic GMP stimulatory potency in nitrate-tolerant LLC-PK1 cells. Hinz B; Schröder H Pharm Res; 1999 May; 16(5):633-6. PubMed ID: 10350003 [TBL] [Abstract][Full Text] [Related]
6. Nitric oxide inhibits vascular bioactivation of glyceryl trinitrate: a novel mechanism to explain preferential venodilation of organic nitrates. Kojda G; Patzner M; Hacker A; Noack E Mol Pharmacol; 1998 Mar; 53(3):547-54. PubMed ID: 9495823 [TBL] [Abstract][Full Text] [Related]
7. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase. Mülsch A; Busse R; Bassenge E Z Kardiol; 1989; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982 [TBL] [Abstract][Full Text] [Related]
8. Effect of the molsidomine metabolite SIN-1 on coronary arteries and peripheral vessels of sheep with special reference to tolerance and endothelium. Yousif MH; Yousif F; Thulesius O Cardiovasc Drugs Ther; 1991 Aug; 5(4):769-73. PubMed ID: 1909561 [TBL] [Abstract][Full Text] [Related]
9. Endothelium- and sydnonimine-induced responses of native and cultured aortic smooth muscle cells are not impaired by nitroglycerin tolerance. Mülsch A; Busse R; Winter I; Bassenge E Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):568-74. PubMed ID: 2570362 [TBL] [Abstract][Full Text] [Related]
10. Nitrate tolerance is specific for nitric acid esters and its recovery requires an intact protein synthesis. Hinz B; Schröder H Biochem Biophys Res Commun; 1998 Nov; 252(1):232-5. PubMed ID: 9813175 [TBL] [Abstract][Full Text] [Related]
11. Nitric oxide liberating, soluble guanylate cyclase stimulating and vasorelaxing properties of the new nitrate-compound SPM 3672. Kojda G; Noack E J Cardiovasc Pharmacol; 1993 Jul; 22(1):103-11. PubMed ID: 7690081 [TBL] [Abstract][Full Text] [Related]
12. Endothelium-dependent vasodilatation in human epicardial coronary arteries: effect of prolonged exposure to glyceryl trinitrate or SIN-1. Kuhn M; Förstermann U J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S47-54. PubMed ID: 2484699 [TBL] [Abstract][Full Text] [Related]
13. A common pathway for nitric oxide release from NO-aspirin and glyceryl trinitrate. Grosser N; Schröder H Biochem Biophys Res Commun; 2000 Jul; 274(1):255-8. PubMed ID: 10903927 [TBL] [Abstract][Full Text] [Related]
14. The effect of peroxynitrite decomposition catalyst MnTBAP on aldehyde dehydrogenase-2 nitration by organic nitrates: role in nitrate tolerance. Mollace V; Muscoli C; Dagostino C; Giancotti LA; Gliozzi M; Sacco I; Visalli V; Gratteri S; Palma E; Malara N; Musolino V; Carresi C; Muscoli S; Vitale C; Salvemini D; Romeo F Pharmacol Res; 2014 Nov; 89():29-35. PubMed ID: 25174989 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of vasodilation by nitrates: role of cyclic GMP. Kukovetz WR; Holzmann S; Romanin C Cardiology; 1987; 74 Suppl 1():12-9. PubMed ID: 2886220 [TBL] [Abstract][Full Text] [Related]
16. Tolerance and cross-tolerance between SIN-1 and nitric oxide in bovine coronary arteries. Kukovetz WR; Holzmann S J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S40-6. PubMed ID: 2484698 [TBL] [Abstract][Full Text] [Related]
17. Nitrate action on epicardial coronary arteries and tolerance: new aspects based on longterm glyceryl trinitrate infusions in dogs. Holtz J; Münzel T; Stewart DJ; Bassenge E Eur Heart J; 1989 Nov; 10 Suppl F():127-33. PubMed ID: 2515966 [TBL] [Abstract][Full Text] [Related]
18. Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cyclic GMP-independent activation of KATP. Csont T; Szilvássy Z; Fülöp F; Nedeianu S; Páli T; Tosaki A; Dux L; Ferdinandy P Br J Pharmacol; 1999 Dec; 128(7):1427-34. PubMed ID: 10602321 [TBL] [Abstract][Full Text] [Related]
19. Nitrovasodilator-induced relaxation and tolerance development in porcine vena cordis magna: dependence on intact endothelium. Kojda G; Beck JK; Meyer W; Noack E Br J Pharmacol; 1994 Jun; 112(2):533-40. PubMed ID: 7521258 [TBL] [Abstract][Full Text] [Related]
20. The role of nitric oxide formation in organic nitrate-induced vasodilation and organic nitrate tolerance. Marks GS; Nakatsu K; McLaughlin B; Kawamoto J; Slack C; Brien JF Z Kardiol; 1989; 78 Suppl 2():18-21; discussion 64-7. PubMed ID: 2555978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]